Anixa Biosciences Inc

ANIX NASDAQ
4.220
+0.220
+5.50%
Closed 16:00 08/16 EDT
Open
4.050
Prev Close
4.000
High
4.250
Low
4.050
Volume
15.56K
Avg Vol (3M)
71.98K
52 Week High
6.86
52 Week Low
3.100
% Turnover
0.08%
Market Cap
84.81M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Anixa Biosciences Inc ANIX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Anixa Biosciences, Inc. is a biotechnology company. The Company is developing a cancer immunotherapy program, which leverages chimeric endocrine receptor t-cell (CER-T) technology, and is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek liquid biopsy technology is a series of non-invasive blood tests for early detection of solid tumors based on the body's immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream. This technology enables cancer detection in its earliest stages in efforts to treat patients when the disease is curable. The Company has developed techniques and protocols for measuring the subtle immunological changes that occur in the blood stream during tumor development. Through its protocols, the Company has detected the biomarkers in the peripheral blood of biopsy verified cancer patients.
MORE >

Recently

Name
Price
%Change